BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...
Blood-based liquid biopsy tests for colorectal cancer (CRC) are in development and may soon hit the market, expanding potential options for patients who refuse traditional colonoscopy. But would they ...
The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...
Please provide your email address to receive an email when new articles are posted on . In a multicenter study, researchers identified two novel protein biomarkers (PLIN2 and RAB14) that demonstrated ...
A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...
SECAUCUS, N.J. and SAN DIEGO, Dec. 1, 2021 /PRNewswire/ -- Physicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting the Decipher ® Prostate Biopsy genomic classifier (GC) may help guide treatment ...
Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly accurate, sensitive, and specific for both NASH ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to ...
Researchers at Johns Hopkins Sidney Kimmel Cancer Center have developed an automated liquid biopsy test that can detect cancer DNA in the blood of patients with metastatic breast cancer within 5 hours ...
Hosted on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
What if a single blood test could determine whether you had one of 14 types of cancer? That's the question posed by a study published in November in the journal Cancer. Conducted by researchers at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results